·一位生物技术投资者表示,13日上午的交易并不能说明生物技术行业低迷的结束。但也有专家认为,13日的交易是个积极信号,有望让2025年的生物医药行业并购迎来良好开端,并持续向好。2025年1月13日,摩根大通医疗健康年会(J.P. Morgan Healthcare Conference,以下简称“JPM大会”)在美国旧金山举行,首日公布的几项交易活动引发关注。有业内人士在会上表示,并购活动的增加...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.